Boehringer Accelerates Adalimumab Dual Pricing Strategy With 81% Discount

Adds Deep-Discounted Unbranded Version Of Cyltezo Biosimilar Rival To Humira In The US

 
• By David Wallace
  
81% pie icon in blue
The unbranded adalimumab biosimilar offers an 81% discount to Humira • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products